We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$619M
AUM Growth
+$611M
Cap. Flow
+$607M
Cap. Flow %
98.01%
Top 10 Hldgs %
54.74%
Holding
713
New
622
Increased
43
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86.7M
2
PM icon
Philip Morris
PM
+$77.6M
3
MO icon
Altria Group
MO
+$31.1M
4
EWJ icon
iShares MSCI Japan ETF
EWJ
+$21.6M
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$21.1M

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$110K
2
HSTM icon
HealthStream
HSTM
+$16.3K
3
PCAR icon
PACCAR
PCAR
+$12.5K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.38%
2 Financials 7.1%
3 Energy 6.16%
4 Healthcare 4.27%
5 Technology 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
276
Adobe
ADBE
$89.5B
$55K 0.01%
+1,051
New +$50.1K
ITT icon
277
ITT
ITT
$17.5B
$55K 0.01%
+1,525
New +$50.8K
STJ
278
DELISTED
St Jude Medical
STJ
$54K 0.01%
+1,001
New +$51.6K
GLNG icon
279
Golar LNG
GLNG
$4.95B
$53K 0.01%
+1,400
New +$51.3K
FTR
280
DELISTED
Frontier Communications Corp.
FTR
$53K 0.01%
+852
New +$55.4K
HOLX
281
DELISTED
Hologic
HOLX
$52K 0.01%
+2,500
New +$53.2K
CSII
282
DELISTED
Cardiovascular Systems, Inc.
CSII
$52K 0.01%
+2,600
New +$54.1K
DNB
283
DELISTED
Dun & Bradstreet
DNB
$52K 0.01%
+502
New +$52.2K
GSK icon
284
GSK
GSK
$103B
$51K 0.01%
+802
New +$51.6K
TEVA icon
285
Teva Pharmaceuticals
TEVA
$35.9B
$51K 0.01%
+1,339
New +$52.2K
VOD icon
286
Vodafone
VOD
$34.9B
$51K 0.01%
+1,416
New +$44.8K
ESRX
287
DELISTED
Express Scripts Holding Company
ESRX
$51K 0.01%
830
+119
+17% +$7.7K
AL
288
DELISTED
Air Lease Corp
AL
$50K 0.01%
+1,800
New +$49.3K
FPO
289
DELISTED
First Potomac Realty Trust
FPO
$50K 0.01%
+4,000
New +$52.7K
ADM icon
290
Archer Daniels Midland
ADM
$41.4B
$49K 0.01%
+1,332
New +$48.5K
ARCC icon
291
Ares Capital
ARCC
$13.5B
$49K 0.01%
+2,746
New +$48.1K
PGR icon
292
Progressive
PGR
$124B
$49K 0.01%
+1,800
New +$46.7K
SWBI icon
293
Smith & Wesson
SWBI
$655M
$49K 0.01%
+5,855
New +$50.6K
FRBK
294
DELISTED
Republic First Bancorp Inc
FRBK
$48K 0.01%
+14,907
New +$49.7K
XLS
295
DELISTED
EXELIS INC COM STK
XLS
$48K 0.01%
+3,268
New +$45.7K
IMH
296
DELISTED
Impac Mortgage Holdings Inc.
IMH
$48K 0.01%
+5,000
New +$50K
PCL
297
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$47K 0.01%
+1,000
New +$46.8K
CNK icon
298
Cinemark Holdings
CNK
$3.82B
$45K 0.01%
+1,417
New +$42.6K
MFIC icon
299
MidCap Financial Investment
MFIC
$784M
$45K 0.01%
+1,786
New +$43.4K
NWSA icon
300
News Corp Class A
NWSA
$14.5B
$45K 0.01%
+2,805
New +$44.8K
10 11
12
13 14

Similar funds

CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
SCM
Steadfast Capital Management New York $2.92B AUM 26.34% 1-Year Est. Return
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $2.93B AUM 4.27% 1-Year Est. Return
CCM
CloudAlpha Capital Management Hong Kong $2.93B AUM 345.92% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
CWM
Calamos Wealth Management Naperville, Illinois $2.91B AUM 25.59% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
FNT
First National Trust Hermitage, Pennsylvania $2.93B AUM 22.18% 1-Year Est. Return

Hirtle Callaghan & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Hirtle Callaghan & Co held 713 positions worth $619M, up 7,069% from $8.64M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hirtle Callaghan & Co deployed $607M of net new capital in Q3 2013, opening 622 new positions and adding to 43 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 17% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was HealthStream, an estimated $16.3K trimmed.

  • Hirtle Callaghan & Co's largest Q3 2013 buy was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.
  • Hirtle Callaghan & Co added most to Philip Morris in Q3 2013, an estimated $77.6M increase.
  • Hirtle Callaghan & Co's biggest Q3 2013 reduction was HealthStream, cutting an estimated $16.3K.
  • Hirtle Callaghan & Co fully exited Community Health Systems in Q3 2013, selling an estimated $110K.
  • Hirtle Callaghan & Co's ten largest holdings make up 55% of its $619M portfolio in Q3 2013.
  • Hirtle Callaghan & Co opened 622 new positions and closed 4 in Q3 2013.
  • Hirtle Callaghan & Co's portfolio value rose 7,069% quarter-over-quarter to $619M.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2013, filed 12 Nov 2013.